Yanis Boumber

About Yanis Boumber

Yanis Boumber, With an exceptional h-index of 26 and a recent h-index of 21 (since 2020), a distinguished researcher at North Western University, specializes in the field of Cancer Biology, Molecular Therapeutics, Lung and Head Neck Cancer, HMTs and RNA binding proteins.

His recent articles reflect a diverse array of research interests and contributions to the field:

Novel chemical degraders targeting NSD2 in head and neck squamous cell carcinoma (HNSCC)

NSD1 supports cell growth and regulates autophagy in HPV-negative head and neck squamous cell carcinoma

Rationally designed inhibitors of the Musashi protein-RNA interaction by hotspot mimicry

Knockout of the histone methyltransferase NSD1 leads to a decrease in cell proliferation and an increase in sensitivity to cisplatin in laryngeal squamous cell carcinoma

Musashi-2 (MSI2) regulation of DNA damage response in lung cancer

361MO Characterizing the role of NSD family of histone methyltransferases in the head and neck squamous cell carcinoma tumor immune microenvironment

EP06. 03-11 Characterization of KRAS Mutations in Black Patients with NSCLC at an Urban Academic Medical Center

Retrospective analysis of NUT carcinoma: The Northwestern experience.

Yanis Boumber Information

University

Position

Robert H Lurie Comprehensive Cancer Center

Citations(all)

3525

Citations(since 2020)

1859

Cited By

2321

hIndex(all)

26

hIndex(since 2020)

21

i10Index(all)

37

i10Index(since 2020)

36

Email

University Profile Page

Google Scholar

Yanis Boumber Skills & Research Interests

Cancer Biology

Molecular Therapeutics

Lung and Head Neck Cancer

HMTs and RNA binding proteins

Top articles of Yanis Boumber

Novel chemical degraders targeting NSD2 in head and neck squamous cell carcinoma (HNSCC)

Cancer Research

2024/3/22

Yanis Boumber
Yanis Boumber

H-Index: 20

NSD1 supports cell growth and regulates autophagy in HPV-negative head and neck squamous cell carcinoma

Cell Death Discovery

2024/2/13

Demirkan Gursel
Demirkan Gursel

H-Index: 14

Yanis Boumber
Yanis Boumber

H-Index: 20

Rationally designed inhibitors of the Musashi protein-RNA interaction by hotspot mimicry

bioRxiv

2023/1/10

Knockout of the histone methyltransferase NSD1 leads to a decrease in cell proliferation and an increase in sensitivity to cisplatin in laryngeal squamous cell carcinoma

Siberian Journal of Oncology

2023

Musashi-2 (MSI2) regulation of DNA damage response in lung cancer

bioRxiv

2023

361MO Characterizing the role of NSD family of histone methyltransferases in the head and neck squamous cell carcinoma tumor immune microenvironment

Annals of Oncology

2023/11/1

EP06. 03-11 Characterization of KRAS Mutations in Black Patients with NSCLC at an Urban Academic Medical Center

Journal of Thoracic Oncology

2023/11/1

Retrospective analysis of NUT carcinoma: The Northwestern experience.

2023/6/1

Yanis Boumber
Yanis Boumber

H-Index: 20

Rui Yi
Rui Yi

H-Index: 23

Regulation of VEGFR2 and AKT signaling by Musashi-2 in lung cancer

Cancers

2023/4/28

Alexander Kudinov
Alexander Kudinov

H-Index: 5

Yanis Boumber
Yanis Boumber

H-Index: 20

NSD1/2 histone methyltransferases regulate cell growth in HPV-negative head and neck squamous cell carcinoma (HNSCC)

Cancer Research

2023/4/4

MSI2 regulates DNA damage response signaling and tumor progression in murine NSCLC

Cancer Research

2023/4/4

PP01. 73 Time from Biopsy to Treatment Initiation at an Academic Hospital and Affiliate Hospitals: Overall Survival Analysis

Journal of Thoracic Oncology

2023/3/1

PP01. 13 Low Screening Rates in Patients Ultimately Diagnosed with Advanced NSCLC

Journal of Thoracic Oncology

2023/3/1

PP01. 49 Analysis of Outcomes by Race in Patients with Advanced NSCLC

Journal of thoracic oncology

2023/3/1

The Prognostic and Therapeutic Potential of DNA Damage Repair Pathway Alterations and Homologous Recombination Deficiency in Lung Cancer

2022/10/28

EP04. 01-008 Factors Impacting Time from Biopsy to Initiation of Treatment for Advanced NSCLC at an Academic Hospital and Affiliate Hospitals

Journal of thoracic oncology

2022/9/1

EP04. 01-007 Impact of Precision Medicine Methods on First-Line Therapies in Metastatic Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

2022/9/1

EP08. 02-028 Germline HRR Mutations in Metastatic NSCLC and Impact on Progression-Free Survival: A Single-Center Retrospective Study

Journal of thoracic oncology

2022/9/1

NSD histone methyltransferases drive cell proliferation in HPV-negative head and neck squamous cell carcinoma (HNSCC)

Cancer Research

2022/6/15

See List of Professors in Yanis Boumber University(North Western University)

Co-Authors

academic-engine